Judy’s Reviews > National Kidney Foundation Primer on Kidney Diseases, E-Book > Status Update
Judy
is 49% done
Drugs in Kidney diseases was mostly forgettable.
AKI was quite good but „novel biomarkers might someday help us“ is just not a very captivating conclusion (no shade to the authors). My August chapters are done but I‘ll keep reading as long as I have a good run. Hereditary kidney disease is next. First chapter is „APOL1 is a mutation that sucks but nothing we can do about it“. 😄
— Aug 20, 2025 05:09AM
AKI was quite good but „novel biomarkers might someday help us“ is just not a very captivating conclusion (no shade to the authors). My August chapters are done but I‘ll keep reading as long as I have a good run. Hereditary kidney disease is next. First chapter is „APOL1 is a mutation that sucks but nothing we can do about it“. 😄
1 like · Like flag
Judy’s Previous Updates
Judy
is 85% done
Three chapters left. Almost done and I think I will fulfill my goal of reading the entire book this year.
— Dec 13, 2025 03:07PM
Judy
is 64% done
Done with my September chapters and even did some of October's. Only three more parts to go (CKD, treatment of kidney failure, hypertension), which coincidentally also are parts that I might be more familiar with than GNs from clinical work. Phew. Reading Brandon Sanderson's Stormlight Archive's first installment for my "fun time" reading during September!
— Sep 23, 2025 02:02PM
Judy
is 39% done
The part on systemic diseases is either lacking, or I‘m just a huge noob. Hoping the next parts will pick up the pace a tad. The chapter on ANCA associated vasculitis was brilliant though - the author of the chapter, Frank B Cortazar, did a marvellous job conveying a difficult topic.
— Jul 24, 2025 01:51PM
Judy
is 25% done
I‘ve taken up some „serious“ reading on the side for a change. I aim to read two parts per month and whenever in the month that is done, I get to read fun stuff again during the rest of the month.
Most of the chapters are written in clear language, dive into the whys and reference current landmark trials, so having a surprisingly good time so far.
— Jul 18, 2025 11:21PM
Most of the chapters are written in clear language, dive into the whys and reference current landmark trials, so having a surprisingly good time so far.